The mobilising effect of political choice

Political choice is central to citizens’ participation in elections. Nonetheless, little is known about the individual-level mechanisms that link political choice and turnout. It is argued in this article that turnout decisions are shaped not only by the differences between the parties (party polarisation), but also by the closeness of parties to citizens’ own ideological position (congruence), and that congruence matters more in polarised systems where more is at stake. Analysing cross-national survey data from 80 elections, it is found that both polarisation and congruence have a mobilising effect, but that polarisation moderates the effect of congruence on turnout. To further explore the causal effect of political choice, the arrival of a new radical right-wing party in Germany, the Alternative for Germany (AfD), is leveraged and the findings show that the presence of the AfD had a mobilising effect, especially for citizens with congruent views

Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA

Item does not contain fulltextHexaminolevulinate (HAL) is a tumour photosensitizer that is used in combination with blue-light cystoscopy (BLC) as an adjunct to white-light cystoscopy (WLC) in the diagnosis and management of non-muscle-invasive bladder cancer (NMIBC). Since being licensed in Europe in 2005, HAL has been used in >200,000 procedures, with consistent evidence that it improves detection compared with WLC alone. Current data support an additional role in the reduction of recurrence of NMIBC. Since the approval of HAL by the FDA in 2010, experience of HAL-BLC in the USA continues to expand. To define areas of need and to identify the benefits of HAL-BLC in clinical practice, a focus group of expert urologists specializing in the management of patients with bladder cancer convened to review the clinical evidence, share their experiences and reach a consensus regarding the optimal use of HAL-BLC in the USA. The focus group concluded that HAL-BLC should be considered for initial assessment of NMIBC, surveillance for recurrent tumours, diagnosis in patients with positive urine cytology but negative WLC findings, and for tumour staging